Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:1630-1637
Published online before print May 6, 2004, doi: 10.1161/01.RES.0000130944.49657.b8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
94/12/1630    most recent
01.RES.0000130944.49657.b8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neri Serneri, G. G.
Right arrow Articles by Chiavarelli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neri Serneri, G. G.
Right arrow Articles by Chiavarelli, M.
Related Collections
Right arrow Acute coronary syndromes
Right arrow ACE/Angiotension receptors
(Circulation Research. 2004;94:1630.)
© 2004 American Heart Association, Inc.


Clinical Research

Cardiac Angiotensin II Participates in Coronary Microvessel Inflammation of Unstable Angina and Strengthens the Immunomediated Component

Gian Gastone Neri Serneri, Maria Boddi, Pietro Amedeo Modesti, Mirella Coppo, Ilaria Cecioni, Thomas Toscano, Maria Letizia Papa, Manuela Bandinelli, Gian Franco Lisi, Mario Chiavarelli

From the Clinica Medica Generale e Cardiologia (G.G.N., M.B., P.A.M., I.C., M.C., M.L.P., M.B., G.F.L.), University of Florence, Italy; and Institute of Thoracic and Cardiovascular Surgery (T.T., M.C.), University of Siena, Italy.

Correspondence to Dr Gian Gastone Neri Serneri, Clinica Medica Generale e Cardiologia, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. E-mail gg.neriserneri{at}dfc.unifi.it

Angiotensin (Ang) II is now recognized to be a mediator of a wide variety of inflammatory processes. This study investigated renin-angiotensin system (RAS) components and a number of inflammatory mediators in left ventricular biopsies from 2-vessel disease unstable angina (UA) (n=43) and stable angina (SA) (n=15) patients undergoing coronary bypass surgery. Biopsy samples from 6 patients undergoing valve replacement for mitral stenosis served as controls. UA patients were randomly assigned to angiotensin-converting enzyme (ACE)-inhibitor (ramipril), AT1 antagonist (valsartan), or placebo and treated during the 5 days preceding coronary bypass surgery, performed from 6 to 9 days after coronary angiography. During coronary angiography coronary blood flow was measured and samples were obtained from aorta and coronary sinus for determination of Ang I and Ang II gradients. The hearts of UA patients produced Ang II in a greater amount than in SA patients (P<0.01). UA biopsy samples showed numerous DR+ cells, identified as lymphocytes, macrophages, and endothelial cells. Reverse-transcriptase polymerase chain reaction showed overexpression of AGTN, ACE, and AT1-R genes, as well as upregulation of TNF-{alpha}, IL-6, IFN-{gamma}, and iNOS genes (P<0.01), with no differences between nonischemic and potentially ischemic areas. AGTN, ACE, and cytokine genes were mainly localized on endothelial cells. Ramipril and valsartan markedly decreased the expression levels of TNF-{alpha}, IL-6, and iNOS, and, to a lesser extent, of IFN-{gamma} genes, but did not affect the number of DR+ cells, with no significant difference between the 2 treatments. These results show that locally generated Ang II amplifies the immunomediated inflammatory process of coronary microvessels occurring in unstable angina.


Key Words: angiotensin II • unstable angina • myocardial inflammation




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Y. Oudit, Z. Kassiri, M. P. Patel, M. Chappell, J. Butany, P. H. Backx, R. G. Tsushima, J. W. Scholey, R. Khokha, and J. M. Penninger
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice
Cardiovasc Res, July 1, 2007; 75(1): 29 - 39.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
Eur. Heart J., April 2, 2007; 28(8): 929 - 940.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Kretowski, K. McFann, J. E. Hokanson, D. Maahs, G. Kinney, J. K. Snell-Bergeon, R. P. Wadwa, R. H. Eckel, L. Ogden, S. Garg, et al.
Polymorphisms of the Renin-Angiotensin System Genes Predict Progression of Subclinical Coronary Atherosclerosis
Diabetes, March 1, 2007; 56(3): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J., January 2, 2006; 27(2): 136 - 149.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. C. Luft
Cardiac Angiotensin Is Upregulated in the Hearts of Unstable Angina Patients
Circ. Res., June 25, 2004; 94(12): 1530 - 1532.
[Full Text] [PDF]